The treatment landscape for small cell lung cancer (SCLC) is continually evolving, thanks to ongoing research to improve outcomes and effective therapies. Combining chemotherapy and immunotherapy remains the standard approach, with clinical trials playing a vital role in discovering [...]
On October 3, 2024, the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab) to be used with platinum-doublet chemotherapy as a treatment before surgery, followed by Opdivo (nivolumab) alone after surgery. This approval is for people with resectable (removable [...]
On September 12, 2024, the U.S. Food and Drug Administration (FDA) announced its approval of Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) for subcutaneous injection, commonly known as a shot. This approval included all the same uses of Tecentriq (atezolizumab) that [...]
On August 15, 2024, the U.S. Food and Drug Administration (FDA) granted approval for the immunotherapy drug Imfinzi (durvalumab) to be used in combination with chemotherapy (neoadjuvant, treatment given before surgery) as well as on its own after surgery (adjuvant). [...]
With recent advancements made in thoracic oncology, the management of non-small cell lung cancer (NSCLC) is evolving rapidly. While chemotherapy, immunotherapy, targeted therapy, molecular testing, and radiotherapy continue to play a large role in the management of lung cancer, [...]
Author: Matthew Reiss, MSE, PhD, Manager, Precision Medicine & Navigation, GO2 for Lung Cancer The first anti-cancer therapy, mechlorethamine, was approved in 1949. Since then, the U.S. Food and Drug Administration (FDA) has worked to ensure that new lifesaving [...]
Question: My mom was recently diagnosed with lung cancer, and her healthcare team recommended radiation as part of her treatment. We don’t know much about radiation yet. What are the different types of radiation therapy, and how are they [...]
Question: I was recently diagnosed with lung cancer and am on my first line of treatment. I keep hearing that at some point I may develop a resistance to that treatment. What exactly does that mean and how long [...]
Contributing Authors: GO2 for Lung Cancer Associate Director, Clinical Research, Andrew Ciupek, PhD and Manager, Precision Medicine & Navigation, Matthew Reiss, MSE, PhD Each year, researchers, physicians, and industry partners gather at the European Society for Medical Oncology [...]
Question: My mom was just diagnosed with lung cancer. What questions should we be prepared to ask at her next doctor’s appointment? Answer: Receiving a lung cancer diagnosis and learning about treatment options can be scary and stressful [...]